Evidence map›Paper›PMID 42804230›Full record

ArticleExperimental and clinical psychopharmacology2026

Effects of simulated and real opioid withdrawal on delay discounting for opioids and money in people who use fentanyl daily.

Thomas P Shellenberg, Tavishi Baidwan, Alexandra N Johansen, Justin C Strickland, Suky Martinez, Sean D Regnier, Michael J Wesley, Shanna L Babalonis, William W Stoops, Joshua A Lile

Abstract read
In one paragraph

Article in Experimental and clinical psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thomas P ShellenbergDepartment of Behavioral Science, University of Kentucky, College of Medicine.ORCID 0009-0003-4186-7727
Tavishi BaidwanDepartment of Psychology, Program in Neuroscience, Davidson College.
Alexandra N JohansenDepartment of Behavioral Science, University of Kentucky, College of Medicine.
Justin C StricklandKahlert Institute for Addiction Medicine, University of Maryland School of Medicine.
Suky MartinezDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.ORCID 0000-0002-4873-8130
Sean D RegnierDepartment of Behavioral Science, University of Kentucky, College of Medicine.
Michael J WesleyDepartment of Behavioral Science, University of Kentucky, College of Medicine.
Shanna L BabalonisDepartment of Behavioral Science, University of Kentucky, College of Medicine.
William W StoopsDepartment of Behavioral Science, University of Kentucky, College of Medicine.
Joshua A LileDepartment of Behavioral Science, University of Kentucky, College of Medicine.ORCID 0000-0002-6237-8557

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
A Translational Determination of the Mechanisms of Maladaptive Choice in Opioid Use DisorderR01DA047368 · NIDA · UNIVERSITY OF KENTUCKY · PI BECKMANN, JOSHUA, LILE, JOSHUA ANTHONY · 2019 to 2023
$3.1M
Interdisciplinary Training in Alcohol ResearchT32AA027488 · NIAAA · UNIVERSITY OF KENTUCKY · PI Mark T Fillmore, Mark A Prendergast · 2019 to 2026
$2.0M
Natural Language Processing Phenotyping of Spirituality and Resilience Among Individuals with Opioid Use DisorderK08DA058057 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Suky Martinez · 2024 to 2026
$655k
Adapting and Testing a Smoking Cessation Intervention in Adults with Intellectual and Developmental DisabilitiesK99DA060267 · NIDA · UNIVERSITY OF KENTUCKY · PI REGNIER, SEAN · 2024 to 2025
$262k
National Institutes of Health; National Institute on Alcohol Abuse and AlcoholismNational Institutes of Health; National Institute on Drug AbuseNCATS NIH HHS UL1 TR001998NIAAA NIH HHS T32 AA027488NIDA NIH HHS K08 DA058057NIDA NIH HHS K99 DA060267NIDA NIH HHS R01 DA047368
6 · The paper itself

Abstract

Delay discounting describes the devaluation of consequences as the delay to their occurrence increases, which can yield a preference for smaller, sooner over larger, later rewards. Conceptual models and preliminary data suggest that delay discounting is exacerbated in deprivation states, including opioid withdrawal, which can shift choice allocation to more immediate rewards. Although withdrawal is hypothesized to affect decision making in opioid use disorder, research that experimentally manipulates withdrawal in people with opioid use disorder is limited by feasibility considerations. Simulated withdrawal manipulations could address this gap, but their validity is not well established. The current analysis compared the effects of real and simulated opioid withdrawal on delay discounting in people with moderate-to-severe opioid use disorder and daily fentanyl use by combining data from two previous studies. Study 1 (

Identifiers

PMID42804230
PMCPMC13623051

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.